Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Vinorelbine, Herceptin and G-CSF in Stage IV Breast Cancer
NCT00041470Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Mar 2001
- Primary completion
- Aug 2008
- Modality
- Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine and Paclitaxel Micelles for Injection in breast cancer, sponsored by University of Washington. Primary endpoints: Response Rates at 1 year, Time to Progression at 1 year and 1 more. Started Mar 2001; status: terminated.
02
Drugs
vinorelbinePaclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00041470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041470.